Home About Us Services Markets Online Trading Back Office Contact Us Download Mutual Fund
Your are on :  Markets   |  News Analysis    |  Corporate Results   |Detailed News   
Back
Brooks Laboratories reports consolidated net loss of Rs 3.96 crore in the September 2024 quarter
09-Nov-24   19:32 Hrs IST

Net Loss of Brooks Laboratories reported to Rs 3.96 crore in the quarter ended September 2024 as against net loss of Rs 1.64 crore during the previous quarter ended September 2023. Sales declined 14.51% to Rs 20.79 crore in the quarter ended September 2024 as against Rs 24.32 crore during the previous quarter ended September 2023.

ParticularsQuarter Ended
Sep. 2024Sep. 2023% Var.
Sales20.7924.32 -15
OPM %-16.40-4.52 -
PBDT-3.53-1.20 -194
PBT-3.96-1.64 -141
NP-3.96-1.64 -141

Powered by Capital Market - Live News

Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores 2.0 Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in
Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR|  Saa₹thi  |  View Client Collateral Details  |  
Vernacular Languages
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)